Company Overview and News
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Evrim Resources Corp. (TSX.V:EVM) (“Evrim” or the “Company”) is pleased to announce that a drilling program has commenced at the Cerro Cascaron gold and silver project in southwestern Chihuahua, Mexico. Evrim and exploration partner, Harvest Gold Corporation (TSX.V:HVG) (“Harvest Gold”), have planned up to 3,000 metres of diamond drilling.
CDE FR HVGDF EVM HVG CDEUW AG
2018-09-25 zacks - 1
Investors in Coeur Mining, Inc. (CDE - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 21, 2018 $15.00 Call had some of the highest implied volatility of all equity options today.
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up.
OCANF EMRRF LUNMF CNL MUN NSU FNLPF TGB THO MUX.RTWI MAG EVM MUNMF MUX SEMFF NEVDF ABX TAHO GPL MUX OKSWF CDEUW BGMZF DRGDF CDE LYDIF NCU OSKGF MAG APR APRLY TKO EXK NEM CPNFD CGOOF LUNCF GSV TECK DGC EDVVF OR TCKRF EDR GG EDV ABX EDVMF DPMLF LUN EVR
Coeur Mining made a move to buy a heap leach gold deposit in Nevada; Northern Star goes to Alaska for its next mine.
RIO RIO GTBDF KGI.DB NST FCX BFDRF GSV NSU BFD RTPPF MUX.RTWI RTNTF MUX GG KL SAND SSL SDDXF KGI MUX KGI.DB.A CDEUW NULGF SNXZF PSPGF NESRF CDE RIO GBR NHRNY
FOOTHILL RANCH, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Kaiser Aluminum Corporation (NASDAQ:KALU) today announced the appointment of Courtney R.B. Lynn to the position of Vice President and Treasurer.
CDE KALU CDEUW
Grand Junction, Colorado, Aug. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE LLC -- Bullfrog Gold Corp (OTCQB:BFGC) (“BFGC” or the “Company”) is pleased to announce new exploration targets with related claim staking, increased gold recoveries from leach tests and the submittal of an environmental permit application at its Bullfrog Project (Project). The Company controls the commanding land and resource positions in the Bullfrog mine area, which is 120 miles NW of Las Vegas and 4 miles west of Beatty, Nevada.
CDE AULGF KOR BFGC AU CDEUW AGG PSPGF CORVF
2018-08-02 bespokepremium - 1
Our recently launched Chart Scanner has become an incredibly popular and useful tool for clients as it gives a user the ability to quickly scan through hundreds of charts in order to find the most attractive (or unattractive) patterns. Included with the tool are a number of pre-defined screens that allow users to see stocks that hit 52-week highs or lows in the previous session, experienced “death” or “golden” crosses, as well as charts which we view as having bullish or bearish patterns.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to CDE / Coeur Mining, Inc. on message board site Silicon Investor.
as of ET